T1	Participants 71 80	leukaemia
T2	Participants 163 189	20 patients with leukaemia
T3	Participants 282 384	20 patients receiving placebo for 14 days after allogeneic matched sibling bone marrow transplantation
T4	Participants 605 624	both patient groups
